These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2630228)

  • 41. The biliary obstruction syndrome of the Chinese.
    HARRISON-LEVY A
    Br J Surg; 1962 May; 49():674-85. PubMed ID: 13904915
    [No Abstract]   [Full Text] [Related]  

  • 42. Isotopic labelling of billary tract stones.
    THOMAS CG; LINKER RL; MORRIS WH
    Surg Forum; 1960; 10():254-7. PubMed ID: 13855050
    [No Abstract]   [Full Text] [Related]  

  • 43. A CASE of CHOLELITHIASIS and BILIARY OBSTRUCTION COMPLICATED by PERITONEAL ABSCESS.
    Brook WF
    Br Med J; 1898 Feb; 1(1936):366-7. PubMed ID: 20757616
    [No Abstract]   [Full Text] [Related]  

  • 44. Defense system in the biliary tract against bacterial infection.
    Sung JY; Costerton JW; Shaffer EA
    Dig Dis Sci; 1992 May; 37(5):689-96. PubMed ID: 1563308
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Secretory immunoglobulin A levels of the bile in cholelithiasis].
    You XY
    Zhonghua Wai Ke Za Zhi; 1989 Mar; 27(3):141-3, 187-8. PubMed ID: 2776552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bile secretory immunoglobulin A in biliary infection and cholelithiasis.
    Yio XY; Jin BW; Yin FZ; Li XJ
    Gastroenterology; 1992 Mar; 102(3):1000-8. PubMed ID: 1537491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum interleukin-6 levels in patients with biliary obstruction.
    Kimura F; Miyazaki M; Suwa T; Sugiura T; Shinoda T; Itoh H; Ambiru S; Shimizu H; Nakagawa K
    Hepatogastroenterology; 1999; 46(27):1613-7. PubMed ID: 10430305
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Intrahepatic IgA and secretory component distribution and the mechanism of hyperSigAnemia].
    Teng MJ
    Zhonghua Wai Ke Za Zhi; 1990 Jul; 28(7):418-20, 446. PubMed ID: 2269049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sequential changes of bile contents in patients with obstructive jaundice from different etiologies.
    Chen CY; Shiesh SC; Su WC; Chang KK; Lin XZ
    Hepatogastroenterology; 1996; 43(10):796-9. PubMed ID: 8884292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical significance of serum secretory immunoglobulin A in cholelithiasis and biliary tract obstruction].
    You XY
    Zhonghua Wai Ke Za Zhi; 1989 Sep; 27(9):550-3, 575. PubMed ID: 2630228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Secretory immunoglobulin A in hepatobiliary diseases.
    Vuitton DA; Seillès E; Cozon G; Rossel M; Bresson-Hadni S; Revillard JP
    Dig Dis; 1991; 9(2):78-91. PubMed ID: 2036735
    [No Abstract]   [Full Text] [Related]  

  • 52. Biliary proteins.
    Reuben A
    Hepatology; 1984; 4(5 Suppl):46S-50S. PubMed ID: 6384005
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.